Recent Finacing
Recent Raise
MYCB1 develops ALETTA, a generative-AI and real-world-evidence platform integrated with in-house pharmaceutical manufacturing, pharmacy operations, and software engineering to deliver end-to-end personalized therapies, certified for Dutch and German markets.
